- Home
- GLU vs ATRA Comparison
GLU vs ATRA Comparison
Compare GLU & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLU
- ATRA
- Stock Information
- Founded
- GLU 2004
- ATRA 2012
- Country
- GLU United States
- ATRA United States
- Employees
- GLU N/A
- ATRA N/A
- Industry
- GLU Finance/Investors Services
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GLU Finance
- ATRA Health Care
- Exchange
- GLU Nasdaq
- ATRA Nasdaq
- Market Cap
- GLU 107.7M
- ATRA 97.0M
- IPO Year
- GLU N/A
- ATRA 2014
- Fundamental
- Price
- GLU $18.20
- ATRA $15.59
- Analyst Decision
- GLU
- ATRA Strong Buy
- Analyst Count
- GLU 0
- ATRA 3
- Target Price
- GLU N/A
- ATRA $21.00
- AVG Volume (30 Days)
- GLU 12.4K
- ATRA 58.0K
- Earning Date
- GLU 01-01-0001
- ATRA 11-06-2025
- Dividend Yield
- GLU 8.60%
- ATRA N/A
- EPS Growth
- GLU N/A
- ATRA N/A
- EPS
- GLU 0.62
- ATRA 0.56
- Revenue
- GLU N/A
- ATRA $188,667,000.00
- Revenue This Year
- GLU N/A
- ATRA N/A
- Revenue Next Year
- GLU N/A
- ATRA N/A
- P/E Ratio
- GLU $22.50
- ATRA $27.68
- Revenue Growth
- GLU N/A
- ATRA 202.41
- 52 Week Low
- GLU $11.61
- ATRA $5.01
- 52 Week High
- GLU $15.40
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- GLU 59.51
- ATRA 58.34
- Support Level
- GLU $17.81
- ATRA $14.14
- Resistance Level
- GLU $18.39
- ATRA $16.15
- Average True Range (ATR)
- GLU 0.27
- ATRA 1.09
- MACD
- GLU -0.00
- ATRA -0.12
- Stochastic Oscillator
- GLU 88.17
- ATRA 58.30
About GLU Gabelli Global Utility of Beneficial Ownership
Gabelli Global Utility & Income Trust is a non-diversified, closed-end management investment company. The Fund's objective is to seek a consistent level of after-tax total return. It predominantly invests in stocks of companies involved to a substantial extent in providing products, services, or equipment for the generation or distribution of electricity, gas, or water and infrastructure operations, and in equity securities including preferred securities of companies in other industries, in each case in such securities that are expected to pay periodic dividends.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).